>
Iran's mountain shelters offer Taiwan a China survival playbook
Exposing the True Evils of the Uniparty: Soros Money, Surveillance, and the Rise of a Third Party
18,000+ Kids Injected With Vaccines While Unconscious At Colorado Hospital
58% Of Americans Get Their News From Four Left-Leaning Aggregators; Study Finds
Modular phone promises total privacy at the flick of a switch
Genetically Engineered War Dogs for 134 Pound Cyborg Dire Wolves Now – Later 600 Pound Wolves
They're Quietly REPLACING Our Food With THIS… And Nobody Is Talking About It!
Chicago Opens First "Teacher-Free" AI School as Global Push Accelerates
Solar Panels Are Doing Something Nobody Expected
DeLorean climbs skyward to race electric flying cars
Atari's 800XL returns with a keyboard, cartridges and BASIC
Bioinspired robot airdrops into remote waters via morphing wing-sail
Anduril interceptor adapts to emerging threats via swappable stages

A stunning medical case is raising new questions about what may still be possible for patients suffering from advanced Alzheimer's disease.
A Japanese-American woman in her 80s who had spent five years barely speaking, unable to walk on her own, and incontinent of urine started talking about her own life again roughly 19 hours after a single oral dose of psilocybin-containing mushrooms, according to a case report published May 28, 2026, in Frontiers in Neuroscience.
The paper, "Transient multidomain functional improvement in advanced Alzheimer's disease following high-dose psilocybin-containing mushroom administration," was written by Marcos Lago, Mariana Cerveira, and Joe Xavier Simonet of the Associação Cruz de Ankh in São Paulo, Brazil. It is one patient. It is not a randomized trial. The authors are explicit that the findings "do not imply disease reversal."
The patient had a clinically diagnosed 10-year history of Alzheimer's disease, including five years of marked hypofunction.
At baseline she spoke mostly in single syllables. She had chronic urinary incontinence, needed help to walk, could not dress herself, had a flat affect, trouble swallowing, and severe loss of spontaneous communication.
She lived under continuous family and caregiver supervision. Formal biomarker confirmation and advanced imaging were not available, and the authors note that a vascular or mixed contribution cannot be fully excluded.
With her son's consent, she was given 5 grams of dried Enigma-strain Psilocybe cubensis by mouth. Importantly, that means 5 grams of mushrooms, not 5 grams of purified psilocybin.
The first stretch was rough. Clinicians suspected hyperthermia. She sweated heavily and dropped into a prolonged deep sleep-like state.
About 19 hours later, near 3:30 a.m., she woke on her own and began an autobiographical conversation that lasted roughly four hours. Her son reported memories and reflections nobody around her had heard her produce in years.
Over the following days the team documented changes across several domains, as reported in the Frontiers paper and summarized by New Scientist and Medical Xpress:
Speech shifted from monosyllables to spontaneous conversation.
Urinary continence returned after more than five years of incontinence, including overnight, with diapers remaining dry.
She walked without assistance by day two.
Within two to three days she was dressing herself and acting on her own initiative.
She held eye contact, smiled back, recognized family, and retrieved contextual details, asking where a person had gone, recognizing a rented car.